Aug 2026· Small· Vol 22, pp.
e75224
· 0 citations· 127 references
Medicine
TL;DR
A review of the evolution of DNA circuits in disease diagnosis, with a focus on how they are becoming increasingly accurate, efficient, and intelligent.
Abstract
Medical decision-making and treatment efficacy depend fundamentally on accurate and early diagnosis. However, conventional diagnostic paradigms often face hurdles related to high invasiveness and a lack of molecular-level accuracy. To overcome these limitations, DNA circuits have flourished as a transformative technology, leveraging programmable dynamic DNA reaction networks to propel the field toward a new frontier of real-time intelligence and high-precision disease theranostics. In this review, we summarized the evolution of DNA circuits in disease diagnosis, with a focus on how they are becoming increasingly accurate, efficient, and intelligent. First, focusing on the input layer of DNA circuits, the evolution of detection targets from single target to multiple targets and multi-dimensional biomarkers was reviewed. Second, focusing on the core architecture of DNA circuits, we analyzed the architectural transition from simple logic gates to scalable and modular circuits that integrate algorithmic logic for intelligent diagnosis, signal amplification for low-abundance targets, and optimize circuit stability. Additionally, we surveyed recent developments in DNA circuits in disease diagnosis, analysis, and treatment. Finally, we discussed the remaining limitations and offer perspectives on the future of intelligent DNA circuits.
This review systematically evaluates the fundamental design principles and advanced applications of DNA circuits in precision diagnostics, and reviews recent advancements in applying DNA circuits to detect various biomarkers, such as nucleic acids and proteins.
Ziwei He, Yiqing Yi, Min Mi et al.· Analytical Methods· 1 citation
Cancer biology has been organized for 2 decades by the hallmarks framework, articulated in 2000 and most recently revised in 2026. The pace of technological change in oncology now requires reframing how cancer is detected, prevented, and treated. This review argues that the hallmarks framework, while historically essen...
Abstract Non-coding RNAs (ncRNAs), once considered genomic dark matter, are now established as key regulators of gene expression with widespread roles in cellular homeostasis and disease. In cancer, ncRNA expression is frequently and systematically dysregulated, and many of these molecules circulate in stable, protecte...
Screening tumor types for which a first-line, integrated DNA-RNA NGS strategy provides a valuable advantage for rapid therapeutic decisions demonstrates that integrated DNA-RNA high-throughput NGS enables timely, precise molecular profiling for personalized therapy in solid tumors.
A. Destro, Federica Panebianco, Cecília Durães et al.· Virchows Archiv· 0 citations
Background: Artificial intelligence (AI) has emerged as a transformative technology in hematology, addressing the increasing complexity of hematologic diagnosis and the growing demand for rapid, accurate, and reproducible interpretation of morphological, immunophenotypic, cytogenetic, and molecular data. Machine learni...
Shweta Chaturvedi, M. M. Aggarwal, Shafaque Zabin et al.· Annals of Pathology and Labo...· 0 citations
While the field of genomic sequencing and DNA-based precision medicine has made tremendous strides, DNA clinical trials are still plagued with numerous problems, such as low recruitment for trials, disparate genomic data integration, difficult biomarker identification, long trial times, and inconsistent treatment decis...
David Raju Kuppala, R. Hariharan· 2026 International Conferenc...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.